European Society of Toxicology In Vitro > Uncategorized > VPH2026: Abstract submission now open!
13 January 2026

VPH2026: Abstract submission now open!

Share your research at the flagship event of the global in silico medicine community in Milan, 1–4 September 2026.

Main topics

  • Trusted AI and modelling in health and care: Ethical, legal and societal dimensions
  • Computational and AI-driven drug delivery and design
  • Credibility assessment, verification and validation of digital twins
  • Decision support systems for clinical applications/technology
  • Imaging for health and diseased conditions
  • Industrial applications of digital twins for healthcare
  • Integrated clinical-in silico case rounds
  • In silico epidemiology
  • In silico oncology
  • In silico organ-on-a-chip
  • In silico toxicology
  • In silico trials
  • Knowledge-driven vs data-driven models in healthcare
  • Modelling health and diseased conditions
  • Multi-omics data integration
  • Neuroinformatics and brain-computer interfaces
  • Regulatory for digital twins
  • Systems biology and multi-scale modelling
  • Tissue-medical device interaction

Deadline: 2 March 2026

Submit now

January 13 @ 8:00 17:00

Related content

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

In Memory of Dr. Alan M. Goldberg (1939–2026)

The European Society of Toxicology In Vitro (ESTIV) joins the international scientific community in mourning the loss of Dr. Alan M. Goldberg, who passed away on 9 June 2026 at the age of 86.

Silver Sponsor

Communication partners

Memorandum of Understanding